Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Switzerland / NCT04117230
Recruiting Observational

CARDSUP - SWISS Circulatory Support Registry

NCT04117230 · tracked via the Priya Life Science Switzerland tracker
Sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Started
2019-08-09
Last updated
2024-12-06

Condition(s) studied

Cardiogenic Shock

Study summary

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age \> 18 years * Medical indication for implantation of a peripheral cannulated VA-ECMO or microaxial flow pump (IMPELLA) or newer LV / LA-Ascending Aorta devices. * Signed informed consent by patient or relative or waived consent by EC Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Universitätsspital Basel Basel Switzerland Recruiting
Insel Gruppe AG, Inselspital Bern Bern Switzerland Recruiting
Luzerner Kantonsspital Lucerne Switzerland Recruiting
Kantonsspital Winterthur Winterthur Switzerland Recruiting
Stadtspital Treimli Zurich Switzerland Recruiting

More Insel Gruppe AG, University Hospital Bern trials in Switzerland

Neck Rescue Access Comparison Enrolling by invitation
Brain Circuitry Changes in Central Poststroke Pain: a Clinical and Neuroimaging Study Recruiting
Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems. Active, not recruiting
Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study Recruiting
Night-to-Night Variability of Novel Physiological Parameters in Home Sleep Apnea Testing Recruiting

Other trials for the same condition

The ECMOCYP (cytochromes P450 Activity) Study Recruiting
BEAT-SHOCK Registry Recruiting
Abiomed Impella RT-DAQ - Observational Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04117230 on ClinicalTrials.gov ↗ ← All trials in Switzerland